Evidence map›Paper›PMID 42243701›Full record

SynthesisBMC infectious diseases2026

Prevalence of Schistosoma haematobium and Schistosoma mansoni co-infection in sub-saharan Africa: a systematic review and meta-analysis.

Adedayo Oluwadamilola Adesida, Oluseyi Ademola Adejumo, Imuetinyan Rashida Edeki, Dapo Sunday Oyedepo, Oladimeji Adedeji Junaid, Temitope Oluwabusola Akinola, Sunkanmi Henry Babatunde, Ayomide Thomas Oluwagbemiga, Kudirat Abimbola Busari, Adenike Christianah Enikuomehin and 22 more

Abstract readSystematic ReviewMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Adedayo Oluwadamilola AdesidaDepartment of Biosciences and Biotechnology, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Oluseyi Ademola AdejumoDepartment of Internal Medicine, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Imuetinyan Rashida EdekiDepartment of Internal Medicine, University of Benin Teaching Hospital, Benin, Edo State, Nigeria.
Dapo Sunday OyedepoDepartment of Internal Medicine, University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria.
Oladimeji Adedeji JunaidDepartment of Internal Medicine, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Temitope Oluwabusola AkinolaDepartment of Internal Medicine, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Sunkanmi Henry BabatundeDepartment of Internal Medicine, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Ayomide Thomas OluwagbemigaDepartment of Internal Medicine, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Kudirat Abimbola BusariZenith Medical and Kidney Centre, Department of Internal Medicine, Federal Capital Territory, Abuja, Nigeria.
Adenike Christianah EnikuomehinDepartment of Internal Medicine, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Titilope Adetoun BamikefaDepartment of Internal Medicine, Osun State University Teaching Hospital, Osogbo, Osun State, Nigeria.
Olutoyin Morenike LawalDepartment of Internal Medicine, Tower Health Phoenixville Hospital, Phoenixville, PA, USA.
Tajudeen Olarenwaju OriadeDepartment of Biosciences and Biotechnology, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Olayinka Vincent OlalekanDepartment of Internal Medicine, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Oyinkansola Aderinsola OmolojaDepartment of Internal Medicine, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Anne Osimokhua ZibiriDepartment of Internal Medicine, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Kofoworola Esther TowolawiDepartment of Internal Medicine, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Olumide Samuel OladunjoyeDepartment of Internal Medicine, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Emmanuel Oluwadamilare DadaDepartment of Internal Medicine, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Olabisi Suliyat BabatundeDepartment of Biosciences and Biotechnology, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Stella Adejoke KayodeCenter for Molecular Biosciences and Biotechnology, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Blessing Mercy BabalolaDepartment of Biosciences and Biotechnology, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Olawale Elijah YisauDepartment of Internal Medicine, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Precious ChukwubemDepartment of Plant Pathology and Entomology, College of Agriculture, Auburn University, Auburn, USA.
Olanrewaju Olumide IgeDepartment of Internal Medicine, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Grace Oghenetega AkinyosoyeDepartment of Internal Medicine, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Godswill Thomas EromoseleDepartment of Internal Medicine, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Victor Ayodeji AjiboyeDepartment of Internal Medicine, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Olusola Samuel OsunyemiDepartment of Biosciences and Biotechnology, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Udeme-Abasi Udoudo NelsonDepartment of Medicine, University College Hospital, Ibadan, Oyo State, Nigeria.
Oyetunde Timothy OyeyemiDepartment of Biosciences and Biotechnology, University of Medical Sciences, Ondo, Ondo State, Nigeria.
Udeme Ekpenyong EkrikpoDivision of Nephrology, Department of Internal Medicine, University of Alabama at Birmingham, Alabama, United States of America. udemeekrikpo@uniuyo.edu.ng.ORCID http://orcid.org/0000-0002-3911-5564

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSchistosomiasis remains a significant public health challenge, especially in Sub-Saharan Africa (SSA). While individual species prevalence is well documented, the global burden of concurrent co-infection remains poorly quantified, despite its significant clinical and therapeutic implications. This study determined the prevalence of Schistosoma haemtobium (Sh) and Schistosoma mansoni (Sm) co-infection in SSA and its variation with age and geographical location.

methodsFollowing PRISMA guidelines, a systematic search of PubMed, African Journal Online, EMBASE and Google Scholar for studies published between 1980 and 2025 reporting Sh and Sm co-infection was conducted. A random-effects model was used to estimate pooled prevalence, with subgroup analyses conducted by geographical region and age. The study protocol was registered with PROSPERO (CRD420251176915).

resultsTwenty-six studies involving 33,121 participants across 11 African countries were included. The overall pooled prevalence of Schistosoma co-infection was 19.1% [95% CI; 12.3%-27.0%, I

conclusionThe prevalence of Schistosoma co-infection is substantial in SSA, particularly within the West African subregion. However, the high heterogeneity observed in this study necessitates a cautious interpretation of the data. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

CoinfectionSchistosoma haematobiumSchistosoma mansoniSchistosomiasis haematobiaSchistosomiasis mansoniAfrica South of the SaharaAnimalsHumansPrevalenceCo-infectionSchistosoma haemtobiumSchistosoma mansoniSub-Saharan Africa

Identifiers

PMID42243701
PMCPMC13455381

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.